Physician profile
Heather Jones
NPI 1346769155
$1,486.62
in general payments reported to CMS, 2019-2025
22 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $330 · 2022: $521 · 2023: $273 · 2024: $144 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $304.66 | 2021-2023 | Senza |
| Horizon Therapeutics Plc | $122.10 | 2022-2023 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $118.07 | 2024-2025 | |
| Abbott Laboratories | $96.82 | 2021-2023 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $93.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.17 | 2022 | |
| Radius Health, INC. | $78.33 | 2021-2025 | Tymlos |
| Stryker Corporation | $78.02 | 2022 | |
| Novo Nordisk INC | $76.96 | 2021-2025 | Wegovy |
| Esperion Therapeutics, INC. | $73.77 | 2021 | |
| Heron Therapeutics, INC. | $55.40 | 2024 | Zynrelef |
| Boston Scientific Corporation | $53.91 | 2021-2023 | Watchman Access System |
| Bioventus LLC | $50.01 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $44.75 | 2021-2023 | Prolia, Evenity |
| Organogenesis INC. | $31.05 | 2025 | Puraply Wound Matrix |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $25.08 | 2025 | Iovera, Zilretta |
| Abbvie INC. | $24.24 | 2024 | |
| Glaxosmithkline, LLC. | $23.86 | 2022 | |
| Baudax Bio INC. | $20.14 | 2022 | |
| Medtronic, INC. | $13.00 | 2023 | Intellis Adaptivestim |
| Takeda Pharmaceuticals U.S.A., INC. | $12.83 | 2022 | |
| Genentech USA, INC. | $6.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.